CoChat

Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice

Open access
Herring, Arne, Münster, Yvonne, Akkaya, Tamer, Moghaddam, Sahar, Deinsberger, Katharina, Meyer, Jakob, Zahel, Julia, Sanchez‐Mendoza, Eduardo, Wang, Yachao, Hermann, Dirk M., Arzberger, Thomas, Teuber‐Hanselmann, Sarah, Keyvani, Kathy · 2016 · Alzheimer's & Dementia
Cited by 48

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Introduction: Memory loss and increased anxiety are clinical hallmarks of Alzheimer's disease (AD). Kallikrein‐8 is a protease implicated in memory acquisition and anxiety, and its mRNA is known to be up‐regulated in AD‐affected human hippocampus. Therefore, an involvement of Kallikrein‐8 in Alzheimer's pathogenesis is conceivable but remains to be proved. Methods: We determined the cerebral expression of Kallikrein‐8 mRNA and protein during the course of AD in patients and in transgenic mice and tested the impact of Kallikrein‐8 inhibition on AD‐related pathology in mice and in primary glial cells. Results: Kallikrein‐8 mRNA and protein were up‐regulated in both species at incipient stages of AD. Kallikrein‐8 inhibition impeded amyloidogenic amyloid‐precursor‐protein processing, facilitated amyloid β (Aβ) clearance across the blood‐brain‐barrier, boosted autophagy, reduced Aβ load and tau pathology, enhanced neuroplasticity, reversed molecular signatures of anxiety, and ultimately improved memory and reduced fear. Discussion: Kallikrein‐8 is a promising new therapeutic target against AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2016.05.006

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 48

Metadata

Authors
Herring, A., Münster, Y., Akkaya, T., Moghaddam, S., Deinsberger, K., Meyer, J., Zahel, J., Sanchez‐Mendoza, E., Wang, Y., Hermann, D. M., Arzberger, T., Teuber‐Hanselmann, S., & Keyvani, K.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2016-06-18
Volume
12
Issue
12
Pages
1273-1287
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2559993415
Cited by
48
References
13
FWCI
5.25
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice. https://app.cochat.ai/papers/10.1016/j.jalz.2016.05.006
The paper
Herring, A., Münster, Y., Akkaya, T., Moghaddam, S., Deinsberger, K., Meyer, J., Zahel, J., Sanchez‐Mendoza, E., Wang, Y., Hermann, D. M., Arzberger, T., Teuber‐Hanselmann, S., & Keyvani, K. (2016). Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2016.05.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.